Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

Emmanuel Gabriel, Enrique Elli, Sanjay Bagaria, Nabil Wasif, Travis Grotz, John Stauffer, Pashtoon M. Kasi, Horacio Asbun

Research output: Contribution to journalArticle

Abstract

Background: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is an appropriate treatment for select patients with peritoneal carcinomatosis. While most commonly performed through an open incision, the laparoscopic approach has been reported and offers short-term benefits. A robotic-assisted approach for carcinomatosis of gastrointestinal origin, however, has not yet been described. Methods: We report our approach to robotic-assisted CRS-HIPEC for a patient with a perforated appendiceal mucocele. Our dynamic video highlights the advantages of this approach. Results: Our patient was a 57-year-old woman with minimal residual disseminated peritoneal adenomucinosis (DPAM), having a peritoneal carcinomatosis index (PCI) score of 1. She had a previous surgical history of a Roux-en-Y gastric bypass. A robotic-assisted approach was utilized using the Intuitive daVinci Xi robotic surgical system through 4 ports. No laparoscopic assistant port was required. The operative time was 426 min, and the estimated blood loss was 50 cc. The greater omentum, falciform ligament, bilateral ovaries, and two small areas of tumor implant were resected. The post-operative length of stay was 4 days, and the patient had regained bowel function by post-operative day 2. Conclusions: Our video demonstrates the feasibility of a robotic-assisted CRS-HIPEC in a patient with minimal, residual DPAM. Similar to a laparoscopic approach, the short-term outcomes are improved as compared to an open approach. An MIS approach to CRS-HIPEC, now with the first-reported robotic-assisted approach, is a viable option for select patients with peritoneal tumors.

Original languageEnglish (US)
Pages (from-to)1-5
Number of pages5
JournalJournal of Robotic Surgery
DOIs
StateAccepted/In press - May 5 2018

Fingerprint

Robotics
Drug Therapy
Carcinoma
Mucocele
Omentum
Gastric Bypass
Operative Time
Ligaments
Ovary
Length of Stay
Neoplasms

Keywords

  • Cytoreductive surgery
  • HIPEC
  • Robotic assisted

ASJC Scopus subject areas

  • Surgery
  • Health Informatics

Cite this

Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). / Gabriel, Emmanuel; Elli, Enrique; Bagaria, Sanjay; Wasif, Nabil; Grotz, Travis; Stauffer, John; Kasi, Pashtoon M.; Asbun, Horacio.

In: Journal of Robotic Surgery, 05.05.2018, p. 1-5.

Research output: Contribution to journalArticle

Gabriel, Emmanuel ; Elli, Enrique ; Bagaria, Sanjay ; Wasif, Nabil ; Grotz, Travis ; Stauffer, John ; Kasi, Pashtoon M. ; Asbun, Horacio. / Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). In: Journal of Robotic Surgery. 2018 ; pp. 1-5.
@article{1bc3f771af114f7a9bf185b33ca97407,
title = "Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)",
abstract = "Background: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is an appropriate treatment for select patients with peritoneal carcinomatosis. While most commonly performed through an open incision, the laparoscopic approach has been reported and offers short-term benefits. A robotic-assisted approach for carcinomatosis of gastrointestinal origin, however, has not yet been described. Methods: We report our approach to robotic-assisted CRS-HIPEC for a patient with a perforated appendiceal mucocele. Our dynamic video highlights the advantages of this approach. Results: Our patient was a 57-year-old woman with minimal residual disseminated peritoneal adenomucinosis (DPAM), having a peritoneal carcinomatosis index (PCI) score of 1. She had a previous surgical history of a Roux-en-Y gastric bypass. A robotic-assisted approach was utilized using the Intuitive daVinci Xi robotic surgical system through 4 ports. No laparoscopic assistant port was required. The operative time was 426 min, and the estimated blood loss was 50 cc. The greater omentum, falciform ligament, bilateral ovaries, and two small areas of tumor implant were resected. The post-operative length of stay was 4 days, and the patient had regained bowel function by post-operative day 2. Conclusions: Our video demonstrates the feasibility of a robotic-assisted CRS-HIPEC in a patient with minimal, residual DPAM. Similar to a laparoscopic approach, the short-term outcomes are improved as compared to an open approach. An MIS approach to CRS-HIPEC, now with the first-reported robotic-assisted approach, is a viable option for select patients with peritoneal tumors.",
keywords = "Cytoreductive surgery, HIPEC, Robotic assisted",
author = "Emmanuel Gabriel and Enrique Elli and Sanjay Bagaria and Nabil Wasif and Travis Grotz and John Stauffer and Kasi, {Pashtoon M.} and Horacio Asbun",
year = "2018",
month = "5",
day = "5",
doi = "10.1007/s11701-018-0820-7",
language = "English (US)",
pages = "1--5",
journal = "Journal of Robotic Surgery",
issn = "1863-2483",
publisher = "Springer London",

}

TY - JOUR

T1 - Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

AU - Gabriel, Emmanuel

AU - Elli, Enrique

AU - Bagaria, Sanjay

AU - Wasif, Nabil

AU - Grotz, Travis

AU - Stauffer, John

AU - Kasi, Pashtoon M.

AU - Asbun, Horacio

PY - 2018/5/5

Y1 - 2018/5/5

N2 - Background: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is an appropriate treatment for select patients with peritoneal carcinomatosis. While most commonly performed through an open incision, the laparoscopic approach has been reported and offers short-term benefits. A robotic-assisted approach for carcinomatosis of gastrointestinal origin, however, has not yet been described. Methods: We report our approach to robotic-assisted CRS-HIPEC for a patient with a perforated appendiceal mucocele. Our dynamic video highlights the advantages of this approach. Results: Our patient was a 57-year-old woman with minimal residual disseminated peritoneal adenomucinosis (DPAM), having a peritoneal carcinomatosis index (PCI) score of 1. She had a previous surgical history of a Roux-en-Y gastric bypass. A robotic-assisted approach was utilized using the Intuitive daVinci Xi robotic surgical system through 4 ports. No laparoscopic assistant port was required. The operative time was 426 min, and the estimated blood loss was 50 cc. The greater omentum, falciform ligament, bilateral ovaries, and two small areas of tumor implant were resected. The post-operative length of stay was 4 days, and the patient had regained bowel function by post-operative day 2. Conclusions: Our video demonstrates the feasibility of a robotic-assisted CRS-HIPEC in a patient with minimal, residual DPAM. Similar to a laparoscopic approach, the short-term outcomes are improved as compared to an open approach. An MIS approach to CRS-HIPEC, now with the first-reported robotic-assisted approach, is a viable option for select patients with peritoneal tumors.

AB - Background: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is an appropriate treatment for select patients with peritoneal carcinomatosis. While most commonly performed through an open incision, the laparoscopic approach has been reported and offers short-term benefits. A robotic-assisted approach for carcinomatosis of gastrointestinal origin, however, has not yet been described. Methods: We report our approach to robotic-assisted CRS-HIPEC for a patient with a perforated appendiceal mucocele. Our dynamic video highlights the advantages of this approach. Results: Our patient was a 57-year-old woman with minimal residual disseminated peritoneal adenomucinosis (DPAM), having a peritoneal carcinomatosis index (PCI) score of 1. She had a previous surgical history of a Roux-en-Y gastric bypass. A robotic-assisted approach was utilized using the Intuitive daVinci Xi robotic surgical system through 4 ports. No laparoscopic assistant port was required. The operative time was 426 min, and the estimated blood loss was 50 cc. The greater omentum, falciform ligament, bilateral ovaries, and two small areas of tumor implant were resected. The post-operative length of stay was 4 days, and the patient had regained bowel function by post-operative day 2. Conclusions: Our video demonstrates the feasibility of a robotic-assisted CRS-HIPEC in a patient with minimal, residual DPAM. Similar to a laparoscopic approach, the short-term outcomes are improved as compared to an open approach. An MIS approach to CRS-HIPEC, now with the first-reported robotic-assisted approach, is a viable option for select patients with peritoneal tumors.

KW - Cytoreductive surgery

KW - HIPEC

KW - Robotic assisted

UR - http://www.scopus.com/inward/record.url?scp=85046463093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046463093&partnerID=8YFLogxK

U2 - 10.1007/s11701-018-0820-7

DO - 10.1007/s11701-018-0820-7

M3 - Article

C2 - 29730733

AN - SCOPUS:85046463093

SP - 1

EP - 5

JO - Journal of Robotic Surgery

JF - Journal of Robotic Surgery

SN - 1863-2483

ER -